UNSPSC 51402207: Etifoxine

This classification denotes an anxiolytic with the molecular formula C17H17ClN2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier X24X82MX4X, chemically known as 6-chloro-2-ethylamino-4-methyl-4-phenyl-4h-3,1-benzoxazine but more generally known as etifoxine, which bears U.S. National Institutes of Health Compound Identifier 30768. European Medicines Agency schedules Etifoxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07302MIG.

UNSPSC 51402207 Etifoxine is a Commodity code that in recent state and local procurement activity covers the purchase of naloxone and drug deactivation systems for community health and emergency response. State and local governments are buying these products to support opioid-overdose countermeasures and controlled substance disposal initiatives. The issuing bodies soliciting under this code include county health and public-safety departments. Vendors must be legally authorized to work in the United States, maintain E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance; drug-free workplace certification is required.

Seminole County, Florida represents recent activity under the code. Seminole County released an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract includes an initial two-year term with a one-year renewal option and a three-month probationary period. Potential FEMA funding introduces compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. The source reflects limited recent-opportunities visibility under this code; additional state and local procurement activity may exist outside the available records.